Immune thrombocytopenic purpura (ITP) is a bleeding disorder and is traditi
onally divided in acute and chronic forms based on the duration of the dise
ase. Chronic ITP is characterized by a persistence of thrombocytopenia for
more than 6 months. Ten to 20% of children with ITP and almost all adults w
ill develop the chronic condition. Pathophysiology of chronic ITP suggests
an autoimmune process and a dysregulated immune response. There are no risk
factors to predict the clinical course of ITP, Controlled clinical trials
are needed to clarify many diagnostic and therapeutic aspects of chronic IT
P, as recently stated by a panel of pediatric and adult hematologists on be
half of The American Society of Hematology (ASH). In this article, we will
focus on pathophysiological, diagnostic, and management aspects of chronic
childhood ITP.